Correspondence 0001213900-23-052005 from INTENSITY THERAPEUTICS, INC. (INTS)
INTENSITY THERAPEUTICS, INC.
Date: June 27, 2023 · CIK: 0001567264 · Accession: 0001213900-23-052005
AI Filing Summary & Sentiment
File numbers found in text: 333-260565
Show Raw Text
CORRESP
1
filename1.htm
Intensity Therapeutics, Inc.
61 Wilton Road, 3rd Floor
Westport, CT 068809
June 27, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE:
Intensity Therapeutics, Inc. (CIK 0001567264)
Registration Statement No. 333-260565 on Form S-1 (the “Registration Statement”)
Ladies and Gentlemen:
Intensity Therapeutics, Inc.
(the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement
pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may become effective
on June 29, 2023 at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable.
The undersigned respectfully
requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, McDermott Will &
Emery LLP, by calling Daniel L. Woodard at (212) 547-5553. The Company hereby authorizes Mr. Woodard to orally modify or withdraw this
request for acceleration.
Very truly yours,
INTENSITY THERAPEUTICS, INC.
By:
/s/ Lewis H. Bender
Lewis H. Bender
Chief Executive Officer